United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 13, 2026 · Filed Apr 14, 2026

On Apr 13, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$574.87 for US$5.46M under a trading plan, leaving 40,513 shares. Filed Apr 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$574.87 average (US$569.78 to US$579.53)
Value
US$5.46M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 13, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 13, 2026Common StockSale35US$569.7849,978Direct
Apr 13, 2026Common StockSale925US$571.3949,053Direct
Apr 13, 2026Common StockSale945US$572.3948,108Direct
Apr 13, 2026Common StockSale1,235US$573.3946,873Direct
Apr 13, 2026Common StockSale1,370US$574.2545,503Direct
Apr 13, 2026Common StockSale1,850US$575.3143,653Direct
Apr 13, 2026Common StockSale1,081US$576.3642,572Direct
Apr 13, 2026Common StockSale1,475US$577.3241,097Direct
Apr 13, 2026Common StockSale384US$578.5240,713Direct
Apr 13, 2026Common StockSale200US$579.5340,513Direct

Source

View original at SEC

Related